Your browser doesn't support javascript.
loading
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Nagler, Arnon; Labopin, Myriam; Dholaria, Bhagirathbhai; Ciceri, Fabio; Fraccaroli, Alessia; Blaise, Didier; Fanin, Renato; Bruno, Benedetto; Forcade, Edouard; Vydra, Jan; Chevallier, Patrice; Bulabois, Claude Eric; Jindra, Pavel; Bornhäuser, Martin; Canaani, Jonathan; Sanz, Jaime; Savani, Bipin N; Spyridonidis, Alexandros; Giebel, Sebastian; Brissot, Eolia; Bazarbachi, Ali; Esteve, Jordi; Mohty, Mohamad.
Afiliação
  • Nagler A; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel.
  • Labopin M; Sorbonne University, Sevice d'hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France; ALWP of the EBMT Paris office, Paris, France.
  • Dholaria B; Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: Bhagirathbhai.r.dholaria@vumc.org.
  • Ciceri F; IRCCS San Raffaele Hospital, University Vita-Salute, Milano, Italy.
  • Fraccaroli A; Hematopoietic Stem Cell Transplantation, Department of Internal Medicine III, University Hospital, Munich, Germany.
  • Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
  • Fanin R; Azienda Ospedaliero Universitaria di Udine, Division of Hematology, Udine, Italy.
  • Bruno B; S.S.C.V. D Trapianto di Cellule Staminali A.O.U Citta della Salute e della Scienza di Torino, Torino, Italy.
  • Forcade E; CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France.
  • Vydra J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Chevallier P; CHU Nantes, Dept. D`Hematologie, Nantes, France.
  • Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Service d`Hématologie, Grenoble, France.
  • Jindra P; Charles University Hospital, Dept. of Hematology/Oncology, Pilsen, Czech Republic.
  • Bornhäuser M; Universitaetsklinikum Dresden Medizinische Klinik und Poliklinik I, Dresden, Germany.
  • Canaani J; Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sanz J; Hospital La Fe, Valencia, Spain.
  • Savani BN; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Spyridonidis A; Hematology Stem Cell Transplant Unit, School of Medicine, University of Patras, Patras, Greece.
  • Giebel S; Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Brissot E; Sorbonne University, Sevice d'hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Esteve J; Hematology Department, Hospital Clinic, Barcelona, Spain.
  • Mohty M; Sorbonne University, Sevice d'hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France; ALWP of the EBMT Paris office, Paris, France.
Transplant Cell Ther ; 28(11): 773.e1-773.e8, 2022 11.
Article em En | MEDLINE | ID: mdl-36031079

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article